Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Daily News

Slight Uptick in Mortality With TAVI in Recent Years: TVT Registry

Caitlin E. Cox

October 18, 2024

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Caitlin E. Cox

September 04, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

Presentation NY Valves 2024

A Reduction in Percent Oversizing of Newer Generation Balloon-Expandable Transcatheter Aortic Valves Does Not Affect Severity of Paravalvular Regurgitation

Presenter: Riya Murugesan

June 06, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

Advertisement

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Slight Uptick in Mortality With TAVI in Recent Years: TVT Registry

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

A Reduction in Percent Oversizing of Newer Generation Balloon-Expandable Transcatheter Aortic Valves Does Not Affect Severity of Paravalvular Regurgitation

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content